Figure 2 | Scientific Reports

Figure 2

From: Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood–brain–barrier in a glioblastoma model

Figure 2

(A, B) MTT assay on the C6 cell line with P NPs, MTX, PTX, P-MTX NPs, P-PTX NPs, MTX + PTX, and P-MTX NPs + P-PTX NPs after 48 h of treatment, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, flow cytometry results of C6 cells (C) control (without treatment) (D) treated with P-PTX NPs and (E) P-MX NP + P-PTX NPs, Q1: necrosis, Q2: late apoptosis, Q3: early apoptosis, and Q4: live cells.

Back to article page